Alkermes Plc (ALKS)
35.39
+0.07
(+0.20%)
USD |
NASDAQ |
May 07, 16:00
35.50
+0.11
(+0.31%)
After-Hours: 07:29
Alkermes Research and Development Expense (Annual) : 318.36M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amarin Corp. Plc | 16.82M |
| Assertio Holdings, Inc. | 1.69M |
| Jazz Pharmaceuticals Plc | 782.74M |
| Xenon Pharmaceuticals, Inc. | 298.40M |
| Tyra Biosciences, Inc. | 102.38M |